ADAD2 and RNF17 Play a Huge Role in Male Fertility

The biological process through which sperm cells are created is called spermatogenesis. It happens in the testes of a sexually mature male. The differentiation of the cells of the testes is dependent greatly on complex cellular events. The majority of these events occur in germ cell granules which are RNA-binding proteins. These proteins are very crucial for spermatogenesis. These granules are essential for appropriate developmental progression in numerous species and are particularly common during meiotic and post-meiotic germ cell differentiation. Recent findings have led to the identification of some RNA targets and the RNA-binding proteins themselves. RNA-binding proteins like ADAD2 and RNF17 have been identified. A study was carried out by Lauren G. Chukrallah et al. In this study, it was determined how ADAD2 granules relate to other granules like RNF17 in terms of their function in the differentiation of male germ cells.

SpermRead Also: Caltech Researchers Make Mouse Embryo From Stem Cells Without the need for Sperm Or Eggs

ADA2 and RNF17 interact

Additional protein components of the ADAD2 granule were found in order to identify it, and its composition was compared to that of other meiotic granules. Furthermore, the function of each protein in relation to the granule itself as well as potential initiators of ADAD2 granule formation was identified. This was done using the mouse as a model and utilizing a variety of single and complex genetic models and high-resolution imaging techniques.

During the study, the subjects used were lab mice. The animal care and use committees at Rutgers University gave their approval to all animal usage protocols. Each mouse was kept in a clean, climate-controlled environment with a 12-hour light cycle. The LabDiet 5058 irradiated rodent chow was fed to the mice, which also had access to food and water. Testes were collected and processed.

Read Also: Declining Sperm Count in Western Men Does Not Necessarily Mean a Decline in Fertility

Results show that ADAD2 interacts with RNF17 which is an RNA-binding protein that is specific to the testes. Also, in the circumstance of the protein mutation, round spermatids with unusual chromocenters can be seen in both Rnf17 and Adad2 mutants. This shows that proteins are very important for sperm production. Male RNF17 mutants have been demonstrated to suffer from significant post-meiotic germ cell loss that results in complete sterility. Furthermore, it was observed that RNF17 localizes uniquely in spermatocytes and is ADAD2 dependent. They also form a distinct germ cell granule which shows that they share development and phenotypic properties. Also, these granules have a specific domain structure that is unique which suggests a spherical structure.

Clinical significance

The knowledge of the role ADAD2 and RNF17 play in reproductive medicine today is very important. Germ cell granules are crucial locations of RNA metabolism necessary for the correct development of human meiotic male germ cells. As a result of underlying spermatogenesis problems, male infertility frequently presents clinically as azoospermia, oligozoospermia, teratozoospermia, and/or asthenozoospermia. With this novel discovery, the pathogenesis of these disorders can be known, and diagnosis and treatment modalities can be improved.

Read Also: A New Cause of Male Infertility Found: Spermatozoa Swimming in Circles


The human body is made up of complex mechanisms and spermatogenesis is one of them. The discovery of binding proteins and how they interact to form metric germ cell granules could be significant in improving fertility rates for males struggling with subfertility.


Two RNA binding proteins, ADAD2 and RNF17, interact to form novel meiotic germ cell granules required for male fertility



Want to Stay Informed?

Join the Gilmore Health News Newsletter!

Want to live your best life?

Get the Gilmore Health Weekly newsletter for health tips, wellness updates and more.

By clicking "Subscribe," I agree to the Gilmore Health and . I also agree to receive emails from Gilmore Health and I understand that I may opt out of Gilmore Health subscriptions at any time.